Volume pricing
| Quantity | Per vial | Save |
|---|---|---|
| 1–4 | 31.00 USDT | — |
| 5–9 | 29.50 USDT | 5% |
| 10–24 | 27.50 USDT | 11% |
| 25–49 | 25.50 USDT | 18% |
| 50+ | 23.50 USDT | 24% |
Tirzepatide
For Research Use Only · Not for Human Consumption
Weight lossMetabolic
Tirzepatide is a synthetic 39-amino-acid peptide that activates both the GIP and GLP-1 incretin receptors. In preclinical and in-vitro models it is studied for receptor crosstalk, cAMP signalling, insulin-secretion kinetics and adipocyte metabolism. Supplied as lyophilized powder at ≥98% HPLC purity. For Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Potential benefits — preclinical research
- •Up to ~20.9% body-weight reduction at 72 weeks in the SURMOUNT-1 trial.
- •Dual GIP / GLP-1 receptor activation studied for superior glycaemic control vs single-agonist incretins.
- •Improved insulin sensitivity and post-prandial glucose excursions in T2D models.
- •Reduced visceral adipose tissue and hepatic fat in preclinical metabolic studies.
- •Lower systolic blood pressure and triglycerides reported as secondary endpoints in clinical trials.
Findings reported in published in-vitro / animal studies. Not therapeutic claims — for research use only.
Certificate of Analysis
View certificate⏱Ships within 15 days — made to order
31.00 USDTper vial
≈ €28.52